These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7592057)

  • 1. Sulfobacins A and B, novel von Willebrand factor receptor antagonists. II. Structural elucidation.
    Kamiyama T; Umino T; Itezono Y; Nakamura Y; Satoh T; Yokose K
    J Antibiot (Tokyo); 1995 Sep; 48(9):929-36. PubMed ID: 7592057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfobacins A and B, novel von Willebrand factor receptor antagonists. I. Production, isolation, characterization and biological activities.
    Kamiyama T; Umino T; Satoh T; Sawairi S; Shirane M; Ohshima S; Yokose K
    J Antibiot (Tokyo); 1995 Sep; 48(9):924-8. PubMed ID: 7592056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfonolipids of gliding bacteria. Structure of the N-acylaminosulfonates.
    Godchaux W; Leadbetter ER
    J Biol Chem; 1984 Mar; 259(5):2982-90. PubMed ID: 6321489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel peptide antagonists for von Willebrand factor binding to the platelet glycoprotein Ib receptor from a phage epitope library.
    South V; Searfoss GH; French S; Cheadle C; Murray E; Howk R; Jaye M; Ricca GA
    Thromb Haemost; 1995 Jan; 73(1):144-50. PubMed ID: 7537918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Panclicins, novel pancreatic lipase inhibitors. II. Structural elucidation.
    Yoshinari K; Aoki M; Ohtsuka T; Nakayama N; Itezono Y; Mutoh M; Watanabe J; Yokose K
    J Antibiot (Tokyo); 1994 Dec; 47(12):1376-84. PubMed ID: 7844032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficient activity of von Willebrand's factor-cleaving protease in patients with disseminated malignancies.
    Oleksowicz L; Bhagwati N; DeLeon-Fernandez M
    Cancer Res; 1999 May; 59(9):2244-50. PubMed ID: 10232615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Ibalpha. Identification of the sulfated tyrosine/anionic sequence Tyr-276-Glu-282 of glycoprotein Ibalpha as a binding site for von Willebrand factor and alpha-thrombin.
    Ward CM; Andrews RK; Smith AI; Berndt MC
    Biochemistry; 1996 Apr; 35(15):4929-38. PubMed ID: 8664285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes.
    Spiel AO; Gilbert JC; Jilma B
    Circulation; 2008 Mar; 117(11):1449-59. PubMed ID: 18347221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absolute Configurations of Some Hydroxy-fatty Acids Produced by the Insect Genus Laccifer.
    Ichikawa A; Takahashi H; Ooi T; Kusumi T
    Biosci Biotechnol Biochem; 1997 Jan; 61(5):881-883. PubMed ID: 28862570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agglutination of platelet-type von Willebrand's disease platelets by bovine von Willebrand factor.
    Takahashi H; Shibata A
    Thromb Haemost; 1985 Apr; 53(2):204-7. PubMed ID: 2992113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Structure and function of the factor VIII/von Willebrand factor complex].
    Müller G
    Z Gesamte Inn Med; 1990 Mar; 45(3):65-8. PubMed ID: 2159676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type IIB von Willebrand factor with normal sialic acid content induces platelet aggregation in the absence of ristocetin. Role of platelet activation, fibrinogen, and two distinct membrane receptors.
    De Marco L; Mazzuccato M; Grazia Del Ben M; Budde U; Federici AB; Girolami A; Ruggeri ZM
    J Clin Invest; 1987 Aug; 80(2):475-82. PubMed ID: 3038958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VCL, an antagonist of the platelet GP1b receptor, markedly inhibits platelet adhesion and intimal thickening after balloon injury in the rat.
    Zahger D; Fishbein MC; Garfinkel LI; Shah PK; Forrester JS; Regnstrom J; Yano J; Cercek B
    Circulation; 1995 Sep; 92(5):1269-73. PubMed ID: 7648675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. von Willebrand factor contained in a high purity FVIII concentrate (Fanhdi) binds to platelet glycoproteins and supports platelet adhesion to subendothelium under flow conditions.
    Rivera J; Escolar G; Casamiquela R; Bravo MI; Jorquera JI; Castillo R; Ordinas A; Vicente V
    Haematologica; 1999 Jan; 84(1):5-11. PubMed ID: 10091386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of platelet receptors for bovine von Willebrand factor on human platelets by a new platelet receptor test.
    Thuy LP; Baugh RF; Brown JE; Hougie C
    Biochim Biophys Acta; 1981 Dec; 678(2):187-93. PubMed ID: 6274414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a point mutation in type IIB von Willebrand disease illustrating the regulation of von Willebrand factor affinity for the platelet membrane glycoprotein Ib-IX receptor.
    Ware J; Dent JA; Azuma H; Sugimoto M; Kyrle PA; Yoshioka A; Ruggeri ZM
    Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2946-50. PubMed ID: 2011604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yakushinamides, Polyoxygenated Fatty Acid Amides That Inhibit HDACs and SIRTs, from the Marine Sponge Theonella swinhoei.
    Takada K; Imae Y; Ise Y; Ohtsuka S; Ito A; Okada S; Yoshida M; Matsunaga S
    J Nat Prod; 2016 Sep; 79(9):2384-90. PubMed ID: 27548648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The acylhalocapnines of halophilic bacteria: structural details of unusual sulfonate sphingoids.
    Baronio M; Lattanzio VM; Vaisman N; Oren A; Corcelli A
    J Lipid Res; 2010 Jul; 51(7):1878-85. PubMed ID: 20211932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further studies on aggregation of platelet-type von Willebrand's disease platelets by human von Willebrand factor.
    Takahashi H; Tatewaki W; Hanano M; Nagayama R; Shibata A
    Thromb Haemost; 1986 Jun; 55(3):338-41. PubMed ID: 3018956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. von Willebrand disease type B: a missense mutation selectively abolishes ristocetin-induced von Willebrand factor binding to platelet glycoprotein Ib.
    Rabinowitz I; Tuley EA; Mancuso DJ; Randi AM; Firkin BG; Howard MA; Sadler JE
    Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9846-9. PubMed ID: 1409710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.